Prolonged exposure to the candidate microbicide C31G differentially reduces cellular sensitivity to agent re-exposure

Biomedicine and Pharmacotherapy

Volumn 59, Issue 8, 2005, Pages 460-468

  Catalone, Bradley J ^a,e   Ferguson, Mary Lee ^b   Miller, Shendra R ^b   Malamud, Dan ^c   Kish Catalone, Tina ^b   Thakkar, Nina J ^b   Krebs, Fred C ^b   Howett, Mary K ^d   Wigdahl, Brian ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d DREXEL UNIVERSITY   (United States)

^e Olympus America Inc   (United States)

Author keywords

C31G; Cytotoxicity; Microbicide

Indexed keywords

AMINE OXIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETAINE DERIVATIVE; C 14 AO; C 16 AO; C 16 B; C 31 G; DODECYL SULFATE SODIUM; LIPID; NONOXINOL 9; PHOSPHOLIPID; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG SENSITIVITY; DRUG TOLERABILITY; EPITHELIUM CELL; FEMALE; HELA CELL; HUMAN; HUMAN CELL; LIPID ANALYSIS; LONG TERM EXPOSURE; PRIORITY JOURNAL; UTERINE CERVIX EPITHELIUM; VAGINA EPITHELIUM;

AMINES; ANTI-INFECTIVE AGENTS; BETAINE; CELL MEMBRANE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FATTY ACIDS, UNSATURATED; HELA CELLS; HUMANS; MEMBRANE LIPIDS; NONOXYNOL; SODIUM DODECYL SULFATE; TIME FACTORS;

EID: 25644448247     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2005.07.009     Document Type: Article

References (33)

1. S.S. Asculai, M.T. Weis, M.W. Rancourt, and A.B. Kupferberg Inactivation of herpes simplex viruses by nonionic surfactants Antimicrob. Agents Chemother. 13 1978 686 690
2. R. Bax, K. Douville, D. McCormick, M. Rosenberg, J. Higgins, and M. Bowden Microbicides - evaluating multiple formulations of C31G Contraception 66 2002 365 368
3. S. Calis, N. Yulug, M. Sumnu, A. Ayhan, and A.A. Hincal A non-antibiotic antimicrobial mixture (C31G): evaluation of the antimicrobial efficiency of C31G on vaginal cultures Boll. Chim. Farm. 131 1992 335 338
4. B.J. Catalone, T.M. Kish-Catalone, L.R. Budgeon, E.B. Neely, M. Ferguson, and F.C. Krebs Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides Antimicrob. Agents Chemother. 48 2004 1837 1847
5. B.J. Catalone, T.M. Kish-Catalone, E.B. Neely, L.R. Budgeon, M.L. Ferguson, and C. Stiller Comparative safety evaluation of the candidate vaginal microbicide C31G Antimicrob. Agents Chemother. 49 2005 1509 1520
6. B.J. Catalone, F.C. Krebs, M. Labib, and B. Wigdahl Broad-spectrum microbicides as a strategy for reducing sexually transmitted disease prevalence and HIV-1 transmission Res. Adv. Antimicrob. Agents Chemother. 2 2001 55 80
7. A.M. Corner, M.M. Dolan, S.L. Yankell, and D. Malamud C31G, a new agent for oral use with potent antimicrobial and antiadherence properties Antimicrob. Agents Chemother. 32 1988 350 353
8. R.N. Fichorova, L.D. Tucker, and D.J. Anderson The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission J. Infect. Dis. 184 2001 418 428
9. D. Hammache, N. Yahi, M. Maresca, G. Pieroni, and J. Fantini Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3) J. Virol. 73 1999 5244 5248
10. M.K. Howett, E.B. Neely, N.D. Christensen, B. Wigdahl, F.C. Krebs, and D. Malamud A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses Antimicrob. Agents Chemother. 43 1999 314 321
11. P. Hug, H.M. Lin, T. Korte, X. Xiao, D.S. Dimitrov, and J.M. Wang Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5 J. Virol. 74 2000 6377 6385
12. D. Johnston, E.R. Matthews, and G. Melnykovych Glucocorticoid effects on lipid metabolism in HeLa cells: inhibition of cholesterol synthesis and increased sphingomyelin synthesis Endocrinology 107 1980 1482 1488
13. Joint United Nations Programme on HIV/AIDS (UNAIDS)/World health organization (WHO) AIDS epidemic update - December 2004 2004 Switzerland Geneva
14. F.C. Krebs, S.R. Miller, D. Malamud, M.K. Howett, and B. Wigdahl Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate Antiviral Res. 43 1999 157 173
15. C.K. Mauck, M.D. Creinin, K.T. Barnhart, S.A. Ballagh, D.F. Archer, and M.M. Callahan A phase I comparative postcoital testing study of three concentrations of C31G Contraception 70 2004 227 231
16. C.K. Mauck, R.G. Frezieres, T.L. Walsh, S.W. Schmitz, M.M. Callahan, and R. Bax Male tolerance study of 1% C31G Contraception 70 2004 221 225
17. C.K. Mauck, D.H. Weiner, M.D. Creinin, K.T. Barnhart, M.M. Callahan, and R. Bax A randomized phase I vaginal safety study of three concentrations of C31G vs. extra strength gynol II Contraception 70 2004 233 240
18. C.W. McConlogue, D. Malamud, and T.K. Vanderlick Interaction of DPPC monolayers with soluble surfactants: electrostatic effects of membrane perturbants Biochim. Biophys. Acta 1372 1998 124 134
19. E.B. Michaels, E.C. Hahn, and A.J. Kenyon Effect of C31G, an antimicrobial surfactant, on healing of incised guinea pig wounds Am. J. Vet. Res. 44 1983 1378 1381
20. S. Niruthisard, R.E. Roddy, and S. Chutivongse The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa Sex. Transm. Dis. 18 1991 176 179
21. J. Piret, J. Lamontagne, J. Bestman-Smith, S. Roy, P. Gourde, and A. Desormeaux In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses J. Clin. Microbiol. 38 2000 110 119
22. W. Popik, T.M. Alce, and W.C. Au Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells J. Virol. 76 2002 4709 4722
23. G. Poste, P. Reeve, D.J. Alexander, and G. Terry Effect of plasma membrane lipid composition on cellular susceptibility to virus-induced cell fusion J. Gen. Virol. 17 1972 133 136
24. R.E. Roddy, M. Cordero, C. Cordero, and J.A. Fortney A dosing study of nonoxynol-9 and genital irritation Int. J. STD AIDS 4 1993 165 170
25. R.J. Shattock, and J.P. Moore Inhibiting sexual transmission of HIV-1 infection Nat. Rev. Microbiol. 1 2003 25 34
26. B. Singh, B. Posti, and J.C. Cutler Virucidal effect of certain chemical contraceptives on Type 2 herpesvirus Am. J. Obstet. Gynecol. 126 1976 422 425
27. M.K. Stafford, H. Ward, A. Flanagan, I.J. Rosenstein, D. Taylor-Robinson, and J.R. Smith Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17 1998 327 331
28. K.A. Thompson, D. Malamud, and B.T. Storey Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9 Contraception 53 1996 313 318
29. J.A. Turpin Considerations and development of topical microbicides to inhibit the sexual transmission of HIV Expert Opin. Investig. Drugs 11 2002 1077 1097
30. T. Uchida Stimulation of phospholipid synthesis in HeLa cells by epidermal growth factor and insulin: activation of choline kinase and glycerophosphate acyltransferase Biochim. Biophys. Acta 1304 1996 89 104
31. L. Van Damme, G. Ramjee, M. Alary, B. Vuylsteke, V. Chandeying, and H. Rees Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial Lancet 360 2002 971 977
32. P.B. Wyrick, S.T. Knight, D.G. Gerbig Jr., J.E. Raulston, C.H. Davis, and T.R. Paul The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro Antimicrob. Agents Chemother. 41 1997 1335 1344
33. K. Yokoyama, M. Suzuki, I. Kawashima, K. Karasawa, S. Nojima, and T. Enomoto Changes in composition of newly synthesized sphingolipids of HeLa cells during the cell cycle - suppression of sphingomyelin and higher- glycosphingolipid synthesis and accumulation of ceramide and glucosylceramide in mitotic cells Eur. J. Biochem. 249 1997 450 455